Histone modifications and chromatin organization in prostate cancer

被引：46

作者：

Chen, Zhong ^{[1
,2
]}

Wang, Liguo ^{[3
]}

Wang, Qianben ^{[1
,2
]}

Li, Wei ^{[3
]}

机构：

[1] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA

[2] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[3] Baylor Coll Med, Houston, TX 77030 USA

来源：

EPIGENOMICS | 2010年 / 2卷 / 04期

关键词：

bioinformatics; CHIA-PET; ChIP-seq; chromatin organization; epigenome; Hi-C; histone modification; next-generation sequencing; prostate cancer; GROUP PROTEIN EZH2; ANDROGEN-RECEPTOR; DNA METHYLATION; HUMAN GENOME; GENE-EXPRESSION; TRANSCRIPT ELONGATION; T-CELLS; EPIGENETICS; POLYCOMB; CHROMOSOME;

D O I：

10.2217/EPI.10.31

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Epigenetic mechanisms, including histone modifications, nucleosomal remodeling and chromosomal looping, contribute to the onset and progression of prostate cancer. Recent technical advances significantly increase our understanding of the genome-wide epigenetic regulation of gene expression in prostate cancer. Aberrant genomic distribution and global level of histone modifications, nucleosome repositioning at the gene promoter and enhancer regions, as well as androgen receptor-mediated chromosomal looping may lead to the silencing of tumor suppressor genes and the activation of proto-oncogenes. In addition, androgen receptor-induced chromosomal looping facilitates recurrent gene fusion in prostate cancer. Studies in epigenetic regulation have translational implications in the identification of new biomarkers and the development of new therapies in prostate cancer.

引用

页码：551 / 560

页数：10

共 90 条

[11] Nucleosome deposition and DNA methylation at coding region boundaries [J].

Choi, Jung Kyoon ;

Bae, Jae-Bum ;

Lyu, Jaemyun ;

Kim, Tae-Yoon ;

Kim, Young-Joon .

GENOME BIOLOGY, 2009, 10 (09)

[12] ETS gene fusions in prostate cancer [J].

Clark, Jeremy P. ;

Cooper, Colin S. .

NATURE REVIEWS UROLOGY, 2009, 6 (08) :429-439

[13] Concepts of epigenetics in prostate cancer development [J].

Cooper, C. S. ;

Foster, C. S. .

BRITISH JOURNAL OF CANCER, 2009, 100 (02) :240-245

[14] Mechanisms of androgen-refractory prostate cancer. [J].

Debes, JD ;

Tindall, DJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1488-1490

[15] Androgen receptor structural and functional elements: Role and regulation in prostate cancer [J].

Dehm, Scott M. ;

Tindall, Donald J. .

MOLECULAR ENDOCRINOLOGY, 2007, 21 (12) :2855-2863

[16] Capturing chromosome conformation [J].

Dekker, J ;

Rippe, K ;

Dekker, M ;

Kleckner, N .

SCIENCE, 2002, 295 (5558) :1306-1311

[17] Gene regulation in the third dimension [J].

Dekker, Job .

SCIENCE, 2008, 319 (5871) :1793-1794

[18]

Diaw L, 2007, GENE REGUL SYST BIO, V1, P313

[19] The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia [J].

Dobosy, Joseph R. ;

Roberts, J. Lea W. ;

Fu, Vivian X. ;

Jarrard, David F. .

JOURNAL OF UROLOGY, 2007, 177 (03) :822-831

[20] Global Levels of Histone Modifications Predict Prostate Cancer Recurrence [J].

Ellinger, Joerg ;

Kahl, Philip ;

von der Gathen, Johannes ;

Rogenhofer, Sebastian ;

Heukamp, Lukas C. ;

Guetgemann, Ines ;

Walter, Bernhard ;

Hofstaedter, Ferdinand ;

Buettner, Reinhard ;

Mueller, Stefan C. ;

Bastian, Patrick J. ;

von Ruecker, Alexander .

PROSTATE, 2010, 70 (01) :61-69

← 1 2 3 4 5 6 7 8 9 →